All Stories

  1. The association between serum ghrelin levels and large-for-gestational-age fetuses in patients with gestational diabetes mellitus
  2. High serum soluble α-Klotho levels in patients with autosomal dominant polycystic kidney disease
  3. Erythropoietin stimulates the coronary collateral development in patients with coronary chronic total occlusion
  4. The comparison of automated urine analyzers with manual microscopic examination for urinalysis automated urine analyzers and manual urinalysis
  5. Serum anti-Müllerian hormone levels in euthyroid adolescent girls with Hashimoto's thyroiditis: relationship to antioxidant status
  6. Investigation of oxidant and antioxidant levels in patients with acute stroke in the emergency service
  7. Determination of Age-Dependent Reference Ranges for Coagulation Tests Performed Using Destiny Plus
  8. Increased ratios of homocysteine/vitamin B12, homocysteine/folate and methionine/vitamin B12 in schizophrenic patients
  9. Relationship between thioredoxin and thioredoxin-binding protein in patients with gestational diabetes mellitus
  10. The Laboratory Should Actively be Involved in the Therapeutic Drug Monitoring (TDM) Process
  11. Irisin as an early marker for predicting gestational diabetes mellitus: a prospective study
  12. Increased serum ghrelin in preeclampsia: Is ghrelin a friend or a foe?
  13. PARAOXONASE1 ACTIVITY AND PHENOTYPE DISTRIBUTION IN MULTIPLE SCLEROSIS
  14. Phenotype distribution of the paraoxonase gene in patients with cardiac disease
  15. The Three Sisters of Fate in Multiple Sclerosis: Klotho (Clotho), Fibroblast Growth Factor-23 (Lachesis), and Vitamin D (Atropos)
  16. High-Dose Hook Effect in 17-Hydroxyprogesterone Assay in a Patient with 21-Hydroxylase Deficiency
  17. Evaluation of circulating betatrophin levels in gestational diabetes mellitus
  18. Investigation of Narcotic Substance Use among Individuals Who were under Probation in The City of Antalya
  19. Balanced oxidative stress index in spite of decreased uric acid levels in multiple sclerosis patients
  20. No association between vitamin D levels and inflammation markers in patients with acute coronary syndrome
  21. Monoclonal Light Chains Can Remain Unnoticed in Protein Electrophoresis
  22. Starburst Crystals in Urine
  23. Decrease of Urotensin II activity can impact on the volume status in predialysis chronic kidney disease
  24. High False Positives and False Negatives in Yeast Parameter in an Automated Urine Sediment Analyzer / Brojni Lažno Pozitivni I Lažno Negativni Rezultati Za Parametar Gljivice Na Automatskom Analizatoru Urina
  25. Increased Antioxidant Quality Versus Lower Quantity Of High Density Lipoprotein In Benign Prostatic Hyperplasia
  26. High prevalence of severe vitamin D deficiency in patients with acute myocardial infarction
  27. HDL functionality and crystal-based sterile inflammation in atherosclerosis
  28. The Cutoff Level for Urine Protein in Urine Immunofixation Electrophoresis
  29. The Diagnostic Value of Oxidative/Antioxidative Balance Parameters in Venous Thromboembolism
  30. Higher serum lipids and oxidative stress in patients with normal tension glaucoma, but not pseudoexfoliative glaucoma
  31. Anticipatory Role of High Density Lipoprotein and Endothelial Dysfunction: An Overview
  32. Decreased HDL-Dependent Paraoxonase and Arylesterase Enzyme Activity May Indicate a Worse Prognosis in Multiple Myeloma
  33. The Acute Effects of Postprandial Hypertriglyceridemia on Coagulation Parameters in Normal and Overweight Individuals
  34. Serum iron metabolism markers including hepcidin in multiple sclerosis patients
  35. Acute Phase Response: Implication in ST-segment Elevation Myocardial Infarction
  36. Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure
  37. Comparison of agilent 1100 (chromsystems) and tosoh hlc-723 g8 hplc systems in thalassemia screening
  38. The Phenotype Distribution of Paraoxonase-1 in Patients with Multiple Myeloma, Bladder, and Colorectal Cancer
  39. HDL-Associated Paraoxonase 1 as a Bridge between Postmenopausal Osteoporosis and Cardiovascular Disease
  40. Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis
  41. Arylestarase and Oxidative Stress in Operating Room Personnel
  42. Positive correlation of serum parathormone and prostate specific antigen levels in prostate cancer
  43. Multiple Myeloma: Relationship to Antioxidant Esterases
  44. Effect of Peripheral Arterial Disease on Serum Ischemia-Modified Albumin Levels in Type 2 Diabetic Patients
  45. Heart valve disease: The role of calcidiol deficiency, elevated parathyroid hormone levels and oxidative stress in mitral and aortic valve insufficiency
  46. Ischemia-Modified Albumin: Could It Be a New Oxidative Stress Biomarker for Colorectal Carcinoma?
  47. Comparison of neurophysiological and mri findings of patients with multiple sclerosis using oligoclonal band technique
  48. Ischemia Modified Albumin Levels and Oxidative Stress in Patients with Bladder Cancer
  49. PP-140 THE ROLE OF ISCHEMIA, ANTIOXIDANT MARKERS AND TYPE 2 DIABETES IN PERIPHERAL ARTERY DISEASE
  50. Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human
  51. ISCHEMIA MODIFIED ALBUMIN LEVELS AND INCREASED OXIDATIVE STRESS IN PATIENTS WITH MULTIPLE MYELOMA / NIVOI ALBUMINA MODIFIKOVANOG ISHEMIJOM I POVI[ENI OKSIDANTNI STRES KOD PACIJENATA SA MULTIPLIM MIJELOMOM